Provenienza dei contatti di primo grado di James Cullem
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark.
13
| Private Company | Pharmaceuticals: Major | 13 |
| Public Company | Pharmaceuticals: Major | 12 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a James Cullem tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
BioNumerik Pharmaceuticals, Inc.
 BioNumerik Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology BioNumerik Pharmaceuticals, Inc. discovers and develops new medicines for cancer treatment. The firm's products include Tavocept which has the potential to substantially increase patient survival in the most common type of lung cancer and possibly many other forms of cancer, and Karenitecin which is an investigational new anti-tumor drug in the camptothecin class of chemotherapy drugs. The company was founded by Frederick H. Hausheer on December 15, 1992 and is headquartered in San Antonio, TX. | Pharmaceuticals: Major | Director/Board Member | |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
CMO Council
 CMO Council Miscellaneous Commercial ServicesCommercial Services CMO Council is a network of executives dedicated to high-level knowledge exchange, thought leadership, and relationship building among senior corporate marketing leaders. The private company is based in Palo Alto, CA, and was founded by Donovan Neale-May. The company provides insights and best practices on various marketing topics, including AI, customer experience, revenue growth, and digital transformation. The company also explore the impact of the pandemic on traditional retailers and the need for agility in recovering from it. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| MALLINCKRODT PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| Drexel University | College/University | Masters Business Admin | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
SSP Technology A/S
 SSP Technology A/S Electrical ProductsProducer Manufacturing SSP Technology A/S designs, develops, and optimizes wind turbine blades. Its product range embraces wind turbine blade technology, mould manufacture, and blade development. The company was founded by Rune Schytt-Nielsen and Flemming Sørensen in 2001 and is headquartered in Stenstrup, Denmark. | Electrical Products | Human Resources Officer | |
Ipsen Ltd.
 Ipsen Ltd. Pharmaceuticals: MajorHealth Technology Ipsen Ltd. develops and markets medicinal products. The firm provides Decapepty, Disport, Hexvix, Increlex and Somatuline. The company is headquartered in Slough, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Copenhagen Business School | College/University | Graduate Degree Masters Business Admin Graduate Degree Undergraduate Degree | |
| West Chester University of Pennsylvania | College/University | Undergraduate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree | |
| University of Southern Denmark | College/University | Undergraduate Degree | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Corporate Officer/Principal | |
BKG Pharma ApS
 BKG Pharma ApS Pharmaceuticals: MajorHealth Technology BKG Pharma ApS develops and commercializes novel antibiotics against multidrug-resistant bacteria. It conducts research and development on treatment for multi-resistant infections such as resistance to chemotherapy. The company was founded by Birgit K. Giwercman in 2004 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Ontario Institute for Cancer Research
 Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | Hospital/Nursing Management | Chairman | |
Adject ApS
 Adject ApS Medical SpecialtiesHealth Technology Adject ApS is a holding company that specializes in the design, development, production, and sales and marketing of auto disable syringes. It engages in the preparation of pharmaceutical compositions. It develops syringe that self-destructs after use. The company was founded by Michael Hans Andranik Hetting on December 22, 2009 and is headquartered in Charlottenlund, Denmark. | Medical Specialties | Director/Board Member | |
Contera Pharma ApS
 Contera Pharma ApS Pharmaceuticals: MajorHealth Technology Contera Pharma ApS is a holding company that identifies and develops treatments for patients suffering from movement disorders. It develops drug candidates based on a combination of repositioning, combinations, and reformulations. The firm's lead project JM-010 is for treatment of dyskinesia associated with Parkinson's disease. It develops an approach of using a combination therapy to tackle clinically relevant synergistic pathways to obtain therapeutic effects which will generate efficacious therapeutic entities based on robust pre-clinical and clinical evidence. The company was founded by Mikael Søndergaard Thomsen and John Bondo Hansen in 2010 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Acesion Pharma ApS
 Acesion Pharma ApS Pharmaceuticals: MajorHealth Technology Acesion Pharma ApS develops drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The firm's technology blocks ion channel with a selective drug molecule constitutes a target for developing treatment of AF. The company was founded by Ulrik Svane S?rensen and Morten Grunnet in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
Conrig Pharma ApS
 Conrig Pharma ApS Pharmaceuticals: MajorHealth Technology Conrig Pharma ApS provides drug for oral treatment of atopical disease. Its new drug (CRG-010) is use for topical treatment of itch/pruritus associated with atopical dermatitis. The company was founded by John Bondo Hansen and Mikael Sondergaard Thomsen on December 20, 2010 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
OncoNOx ApS
 OncoNOx ApS Pharmaceuticals: MajorHealth Technology OncoNOx ApS provides drugs for the treatment of autoimmune diseases and cancer. It is a pharmaceutical company that transforms marketed drugs into proprietary molecules with anti-cancer and/or anti-inflammatory properties. The firm's projects include OX1001 and OX27-NO is a potent anti-cancer compounds in vitro and in vivo and are intended for the treatment of cancer, and OX1001 also exhibits anti-viral activity and is in development for treatment of human immunodeficiency virus (HIV) and acquired immune deficiency syndrome patients with or without HIV related cancer. The company was founded by Ferdinando Nicoletti, Gianni Garotta, Yousef Al-Abed, Marco Donia, and Mai-Britt Zocca in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
GE Healthcare, Inc.
 GE Healthcare, Inc. Medical SpecialtiesHealth Technology GE Healthcare, Inc. manufactures and distributes diagnostic imaging agents and radiopharmaceuticals for imaging modalities that are used in medical imaging procedures. It offers dyes that are used in magnetic-resonance-imaging procedures. The firm also manufactures medical diagnostic equipment including CT image machines. It develops healthcare technological solutions for medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery and biopharmaceutical manufacturing. The company was founded in 1994 and is headquartered in Princeton, NJ. | Medical Specialties | Sales & Marketing | |
Allarity Therapeutics Europe ApS
 Allarity Therapeutics Europe ApS Pharmaceuticals: MajorHealth Technology Allarity Therapeutics Europe ApS operates as a pharmaceutical company that provides oncology products. The firm engages in diagnostics and drug development. The company was founded by Steen Meier Knudsen on August 1, 2012 and is headquartered in Hørsholm, Denmark. | Pharmaceuticals: Major | Chairman Founder Chief Operating Officer Director/Board Member Corporate Officer/Principal | |
| Medical Prognosis Institute, Inc. | Director/Board Member Chief Executive Officer | ||
Diet4life ApS
 Diet4life ApS BiotechnologyHealth Technology Diet4life ApS produces dietary supplements to reduce fat accumulation and induce weight loss in the human body. It evaluate the long-term effects of regular protein intake in conjunction with certain food products and the suitability for being a dietary supplement. The company was founded on March 4, 2013 and is headquartered in Aarhus, Denmark. | Biotechnology | Director/Board Member | |
| CURASIGHT A/S | Medical Specialties | Director/Board Member | |
Blue Ocean Robotics ApS
 Blue Ocean Robotics ApS Industrial MachineryProducer Manufacturing Blue Ocean Robotics ApS develops and introduces market-ready robots for industry, healthcare, education, agriculture and construction. The company was founded by Claus Risager and is headquartered in Odense, Denmark. | Industrial Machinery | Corporate Officer/Principal | |
| INITIATOR PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Chairman | |
Liplasome Pharma ApS
 Liplasome Pharma ApS Pharmaceuticals: MajorHealth Technology Liplasome Pharma ApS operates as a biotech company focusing on oncology. It develops drug delivery technologies for anticancer market. The firm's drug delivery platform consists of a lipid based drug delivery system for the intravenous transportation of anticancer drugs and prodrugs. The company was founded in 2002 and is headquartered in Hoersholm, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Oncology Venture US, Inc.
 Oncology Venture US, Inc. Miscellaneous Commercial ServicesCommercial Services Oncology Venture US, Inc. develops therapies for cancer treatment. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Director/Board Member Chief Executive Officer | |
| Besst-Test ApS | Chairman | ||
| Biotech Af 14 Maj 2014 ApS | Director/Board Member | ||
| Victorious Medical Systems ApS | Director/Board Member | ||
| Mpi Holding ApS | Corporate Officer/Principal | ||
| CESSATECH A/S | Pharmaceuticals: Major | Chairman | |
| BIOSERGEN AB | Biotechnology | Director/Board Member Director of Finance/CFO | |
| Bjørn Svendsen København A/S | Director/Board Member | ||
| CHOSA ONCOLOGY AB | Miscellaneous Commercial Services | Chief Operating Officer Director/Board Member | |
| Buhl Krone Holding ApS | Chief Executive Officer |
Statistiche
Distribuzione geografica
| Danimarca | 30 |
| Stati Uniti | 15 |
| Svezia | 5 |
| Irlanda | 2 |
| Regno Unito | 2 |
Settori
| Health Technology | 31 |
| Consumer Services | 7 |
| Commercial Services | 4 |
| Producer Manufacturing | 3 |
| Consumer Non-Durables | 2 |
Posizioni
| Director/Board Member | 115 |
| Corporate Officer/Principal | 56 |
| Chairman | 38 |
| Independent Dir/Board Member | 36 |
| Chief Executive Officer | 24 |
Contatti più connessi
| Insiders | |
|---|---|
| Gunnar Magnus Modee Persson | 51 |
| Steve Carchedi | 22 |
| Frank Knudsen | 21 |
| Gail Maderis | 20 |
| Duncan Moore | 19 |
| Henrik Kristian Moltke | 16 |
| Robert Oliver | 14 |
| Gerald McLaughlin | 12 |
| Ulla Hald Buhl | 12 |
| Marie Foegh | 12 |
| Claus Frisenberg Pedersen | 11 |
| Jens Knudsen | 10 |
| Niels Laursen | 9 |
| Steen Meier Knudsen | 9 |
| David Roth | 9 |
- Borsa valori
- Insiders
- James Cullem
- Connessioni Società
